Shkreli loses bid to toss stock manipulation conviction
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Retrophin (RTRX) Tops Q4 EPS by 26c, Beats on Revenues
February 27, 2018 4:38 PM ESTRetrophin (NASDAQ: RTRX) reported Q4 EPS of $0.07, $0.26 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $42.18 million versus the consensus estimate of $41.71 million.
Net loss for the fourth quarter of 2017 was $17.6 million, or $0.45 per basic share, compared... More